CDMO News
Eurofins CDMO Alphora Invests in New 50,000 sq ft Biologics Facility in Canada
Eurofins CDMO Alphora has announced plans to build a new biologics manufacturing facility in Mississauga, Ontario. The 50,000 sq ft GMP facility will produce monoclonal antibodies (mAbs) and protein therapies for clinical and commercial use. This development is part of
25 September 2024